Management of neuronopathic Gaucher disease: A European consensus
- 1 June 2001
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 24 (3), 319-327
- https://doi.org/10.1023/a:1010514614570
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Ocular Motor Abnormalities in Gaucher DiseaseNeuropediatrics, 1999
- Prospective study of neurological responses to treatment with macrophage‐targeted glucocerebrosidase in patients with type 3 Gaucher's diseaseAnnals of Neurology, 1997
- Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotypeThe Lancet, 1995
- TEN YEARS' EXPERIENCE OF BONE MARROW TRANSPLANTATION FOR GAUCHER DISEASETransplantation, 1995
- New Gaucher disease mutations in exon 10: a novel L444R mutation produces a new Ncil site the same as L444PHuman Molecular Genetics, 1994
- Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher's diseaseNeurology, 1993
- Enzyme Replacement Therapy of Infantile Gaucher DiseaseNeuropediatrics, 1993
- Rapidly Progressive Type III Gaucher Disease: Deterioration Following Partial SplenectomyActa Paediatrica, 1990
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989
- Gaucher disease‐Norrbottnian type (III)Acta Paediatrica, 1986